Which Mendelian variants matter most for Collies?
The Mendelian-disease table above lists variants screened in 1,207 Collies (Donner 2023). Two dominate by carrier frequency and clinical impact.
Collie Eye Anomaly (CEA)
Collie Eye Anomaly in Collies is an autosomal-recessive developmental eye condition caused by a variant in the NHEJ1 gene. Affected dogs have retinal hypoplasia, choroidal hypoplasia, or in severe cases retinal detachment and blindness. The condition is present at birth and does not progress after early development.
72.2% of Collies in the Donner cohort carry at least one copy of the variant (n=1,207). That is nearly three in four. Testing is widely available through breed-club recommended laboratories. The Collie Club of America health committee recommends testing breeding stock and has maintained CEA screening protocols for decades.
MDR1 (Multidrug Resistance 1) Medication Sensitivity
MDR1 medication sensitivity in Collies is an autosomal-dominant condition caused by a variant in the ABCB1 gene. Dogs carrying the variant have reduced drug efflux in the blood-brain barrier and are hypersensitive to certain medications, most commonly ivermectin (used for heartworm prevention and parasite treatment). A standard dose can cause neurological toxicity: tremors, ataxia, lethargy, or death.
56.4% of Collies in the Donner cohort carry the variant (n=1,207). Donner S4 found only 1 of 2 at-risk dogs phenotype-confirmed, putting the maximum observed penetrance at 50%. The risk is real and avoidable with drug selection. Testing is available through commercial DNA panels. Any Collie with a positive MDR1 result should have a flag in their veterinary record to avoid ivermectin and related avermectins.
Degenerative Myelopathy (DM)
Degenerative Myelopathy in Collies is an autosomal-recessive condition with incomplete penetrance caused by a variant in the SOD1 gene. Affected dogs develop progressive rear-limb weakness and spinal-cord degeneration, typically in middle or older age. The condition is progressive and ultimately paralyzing.
12.6% of Collies carry at least one copy of the variant (n=1,207). Testing is available. Not every dog with two copies becomes symptomatic, which is why the inheritance is described as incomplete penetrance. The breed-club health committee monitors DM cases and recommends testing for breeding decisions.
Bardet-Biedl Syndrome 2 or Progressive Retinal Atrophy (BBS2-PRA) and Exercise-Induced Collapse (EIC)
Bardet-Biedl syndrome 2 (BBS2-PRA) in Collies is an autosomal-recessive retinal degeneration causing progressive vision loss. Exercise-Induced Collapse in Collies is an autosomal-recessive condition with incomplete penetrance that causes collapse during or after intense exercise.
Both variants appear at less than 0.1% carrier frequency in the Donner cohort (n=1,207). Neither is a present breeding concern in the current population.
How should I test my Collie?
A breed-specific panel from a CLIA-accredited laboratory is the high-yield path. The essential set for Collies is CEA, MDR1, and DM. The Collie Club of America maintains a list of recommended testing laboratories on their health pages.
What should I feed a Collie?
Feeding a Collie well means feeding around the breed’s known genetic vulnerabilities. The most consequential is MDR1 medication sensitivity, which shapes parasite-prevention and medication choices for every Collie. Two other genetics matter: DM’s mid-life onset window and the breed’s moderate hip dysplasia signal.
Heartworm and intestinal parasite prevention is MDR1-sensitive. Ivermectin (in Heartgard and many parasite treatments) is dangerous for Collie carriers of the MDR1 variant. This does not mean the diet itself changes, but it means the owner cannot use the most common and cheapest heartworm preventive. Milbemycin oxime (Interceptor) or spinosad (Comfortis) are ivermectin-free alternatives. The dietary consequence is minimal: the diet itself does not change, only the choice of parasite-prevention product.
Joint care matters for the breed’s hip dysplasia frequency. The Orthopedic Foundation for Animals reports 4.4% hip dysplasia prevalence across 10,547 Collie evaluations (OFA breed statistics, ofa.org/diseases/hip-dysplasia/, accessed 2024). This is lower than many large breeds but not negligible. A large-breed puppy formulation with controlled calcium (0.8-1.2% dry matter) and a calcium-to-phosphorus ratio between 1.1:1 and 2:1 supports healthy skeletal development. Adult-life weight management and moderate exercise (avoiding sprinting and jumping in growing puppies until 12 months of age) are equally important.
Degenerative Myelopathy becomes relevant in the second half of life. DM typically emerges between ages 5 and 14 in affected dogs, based on reported SOD1-associated DM case series (Awano et al. 2009, PNAS 106:2794-2799). There is no proven dietary prevention, but maintaining a lean body condition and joint mobility through appropriate exercise may slow progression. Antioxidant support (vitamin E and selenium at NRC 2006 levels or modestly above) is often recommended by neurologists, though the evidence base is limited. Standard adult maintenance diets with adequate antioxidants are sufficient unless a veterinarian flags a specific need.
Grain inclusion or exclusion is not a genetic vulnerability for Collies. The breed has no documented association with diet-related dilated cardiomyopathy as Goldens do. A grain-inclusive diet is no more protective for Collies than a grain-free one from a genetic standpoint. The choice is nutritional and economic, not a breed-specific mandate.
What we don’t know
The penetrance of MDR1 sensitivity is incompletely characterized. Donner S4 reported only 1 of 2 at-risk dogs phenotype-confirmed; the maximum penetrance is 50%. This means some Collies with the MDR1 variant will tolerate ivermectin exposure without overt toxicity, while others will show severe reactions. We do not yet know which individual dogs will react and which will not.
Degenerative Myelopathy’s incomplete penetrance is also unsettled. Not every Collie homozygous at the SOD1 locus becomes symptomatic. Environmental and genetic modifiers may govern whether a carrier develops clinical signs. The published analyses have not yet identified those modifiers.
CEA’s severity is heritable but incompletely predictable from genotype alone. Two affected littermates from the same cross may show different degrees of retinal involvement. The breed-club health surveys have documented this variation but the genetic basis remains unresolved.
Frequently asked questions about Collies
Are Collies good with children? Collies were bred for herding and have strong herding instinct toward moving objects, including small children. With socialization and training, they are typically gentle and patient. Supervision with young children is important, as is teaching children not to trigger herding behavior through running.
What is the most common genetic disease in Collies? Collie Eye Anomaly, caused by a variant in the NHEJ1 gene. 72.2% of Collies carry at least one copy (Donner 2023, n=1,207). Severity ranges from subclinical to blindness, with most carriers showing mild hypoplasia that does not affect vision.
Should I do a DNA test on my Collie? For breeding stock, yes. The Collie Club of America recommends testing for CEA, MDR1, and DM. Pet owners whose Collie will receive ivermectin-based parasite treatments should test for MDR1 to guide medication choices.
What should I avoid giving my Collie? Ivermectin-based heartworm preventives and parasite treatments if your Collie carries the MDR1 variant. The standard dose can cause severe neurological toxicity. Test first or ask your veterinarian about non-ivermectin alternatives like milbemycin oxime.
How long do Collies live? Breed-club surveys and OFA data align on a median lifespan near 12 years for Collies (Collie Club of America health pages, collieclub.net). Breed-club estimates align with this range. Collies are generally considered a long-lived breed within the large-breed category.
What is the best diet for a Collie? A balanced, age-appropriate diet from a manufacturer that runs feeding trials. For puppies, prioritize controlled calcium and a calcium-to-phosphorus ratio of 1.1:1 to 2:1. Avoid ivermectin-based parasite treatments; plan heartworm prevention around MDR1 status. In middle age and beyond, maintain lean body condition to support joint health and potentially slow DM progression if your dog is at genetic risk.
Can Collies compete in agility or dock diving? Yes, with caveats. Collies are athletic and capable of competitive sports. However, if your Collie carries the Exercise-Induced Collapse variant (currently rare in the breed), intense sprinting or sustained high-intensity activity may trigger collapse. Genetic testing is available; most Collies are not carriers and can safely train intensively.
Do Collies need special grooming? Collies have a double coat that sheds heavily. Brushing several times per week is standard maintenance. Shedding intensifies during spring and fall coat blows. This is cosmetic, not health-related, but it is worth planning for if you are a new owner.
Related reading
- The Collie Club of America Health Resources
- Sniff’s Dog Food Methodology
- OFA Hip Dysplasia Statistics
- MDR1 and Ivermectin Sensitivity
- The Pledge